Abstract:
A ratio - first order derivative - zero crossing UV-Visible (UV-Vis) spectrophotometric method has been developed for the simultaneous determination of amoxicillin (Amox), levofloxacin (Levo) and lansoprazole (Lanso). The method was validated for the mixtures of Amox, Levo and Lanso in the standard solutions and pharmaceutical tablets. Amox, Levo and Lanso solutions prepared in MeOH:H2O (50:50 v/v) solvent mixture were used in the measurements. The calibration graphs were prepared at the wavelengths of 248.9, 219.4 and 262.8 nm, respectively, which were determined as the zero crossing points of the ratio - first order derivative spectra of them. The calibration curves were optimized linearly between the concentrations of 1.22 - 15.0 mg/L for Lanso, 0.95 - 20.0 mg/L for Levo and 3.42 - 40 mg/L for Amox together with the correlation coefficients (R-2) 0.9996, 0.9993 and 0.9987, respectively. The limits of detection (LODs) of the improved method were <= 1.03 mg/L concentration, and the limits of quantification (LOQs) were <= 3.42 mg/L. The proposed ratio- first order derivative zero-crossing method was validated with good accuracies as the recoveries of 100.0%, 102.5% and 99.2% and with high precisions as the RSDs % of 1.37, 2.04 and 2.64 for Amox, Levo and Lanso, respectively. It was shown that the Amox, Levo and Lanso can be determined simultaneously without any separation in pharmaceutical mixture formulations.
Description:
Bu yayın 06.11.1981 tarihli ve 17506 sayılı Resmî Gazete’de yayımlanan 2547 sayılı Yükseköğretim Kanunu’nun 4/c, 12/c, 42/c ve 42/d maddelerine dayalı 12/12/2019 tarih, 543 sayılı ve 05 numaralı Üniversite Senato Kararı ile hazırlanan Sakarya Üniversitesi Açık Bilim ve Açık Akademik Arşiv Yönergesi gereğince açık akademik arşiv sistemine açık erişim olarak yüklenmiştir.